Bevacizumab Slows Progression Of Metastatic Breast Cancer But Has No Impact On Surviv

[News]

The cancer drug bevacizumab (Avastin®) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers...

More... (http://www.medicalnewstoday.com/releases/247684.php)